C
At CAMP4 Therapeutics, we are pioneering a novel approach to programmable therapeutics. We combine a deep understanding of regulatory RNA and gene expression with a complementary and customizable oligonucleotide modality. Our platform’s proprietary insights enable us to harness the power of RNA to upregulate the expression of genes and unlock the potential to create treatments for hundreds of diseases affecting millions of patients. Join us at the forefront.
Investor insights
Funding rounds participated in
$100M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2016
Funding rounds raised
Total raised
$100M
from 2 investors over 1 rounds
C
CAMP4 Therapeutics raised $100M on August 20, 2022
Investors: Enavate Sciences and + 5 Other investors